For: | Lendvai G, Jármay K, Karácsony G, Halász T, Kovalszky I, Baghy K, Wittmann T, Schaff Z, Kiss A. Elevated miR-33a and miR-224 in steatotic chronic hepatitis C liver biopsies. World J Gastroenterol 2014; 20(41): 15343-15350 [PMID: PMC4223268 DOI: 10.3748/wjg.v20.i41.15343] |
---|---|
URL: | https://www.wjgnet.com/1007-9327/full/v20/i41/15343.htm |
Number | Citing Articles |
1 |
Gábor Lendvai, Tímea Szekerczés, Benedek Gyöngyösi, Krisztina Schlachter, Endre Kontsek, Adrián Pesti, Attila Patonai, Klára Werling, Ilona Kovalszky, Zsuzsa Schaff, András Kiss. MicroRNA Expression in Focal Nodular Hyperplasia in Comparison with Cirrhosis and Hepatocellular Carcinoma. Pathology & Oncology Research 2019; 25(3): 1103 doi: 10.1007/s12253-018-0528-z
|
2 |
Maneesh Kumar, Ganesh Chandra Sahoo, Vidya Nand Rabi Das, Kamal Singh, Krishna Pandey. A Review of miRNA Regulation in Japanese Encephalitis (JEV) Virus
Infection. Current Pharmaceutical Biotechnology 2024; 25(5): 521 doi: 10.2174/0113892010241606231003102047
|
3 |
Mohamed Zaiou. Noncoding RNAs as additional mediators of epigenetic regulation in nonalcoholic fatty liver disease. World Journal of Gastroenterology 2022; 28(35): 5111-5128 doi: 10.3748/wjg.v28.i35.5111
|
4 |
Sarina Vogt, Diana Handke, Hermann M. Behre, Thomas Greither. Decreased Serum Levels of the Insulin Resistance-Related microRNA miR-320a in Patients with Polycystic Ovary Syndrome. Current Issues in Molecular Biology 2024; 46(4): 3379 doi: 10.3390/cimb46040212
|
5 |
Yu Sun, Yongming Shen, Xiurui Liang, Huilin Zheng, Yitong Zhang. MicroRNAs as Biomarkers and Therapeutic Targets for Nonalcoholic Fatty Liver Disease: A Narrative Review. Clinical Therapeutics 2023; 45(3): 234 doi: 10.1016/j.clinthera.2023.02.001
|
6 |
Zhichao Liu, Yuping Wang, Jürgen Borlak, Weida Tong. Mechanistically linked serum miRNAs distinguish between drug induced and fatty liver disease of different grades. Scientific Reports 2016; 6(1) doi: 10.1038/srep23709
|
7 |
Sara R. Selitsky, Timothy A. Dinh, Cynthia L. Toth, C. Lisa Kurtz, Masao Honda, Benjamin R. Struck, Shuichi Kaneko, Kasey C. Vickers, Stanley M. Lemon, Praveen Sethupathy, Mary K. Estes. Transcriptomic Analysis of Chronic Hepatitis B and C and Liver Cancer Reveals MicroRNA-Mediated Control of Cholesterol Synthesis Programs. mBio 2015; 6(6) doi: 10.1128/mBio.01500-15
|
8 |
Maurice C. J. M. Konings, Sabine Baumgartner, Ronald P. Mensink, Jogchum Plat. Investigating microRNAs to Explain the Link between Cholesterol Metabolism and NAFLD in Humans: A Systematic Review. Nutrients 2022; 14(23): 4946 doi: 10.3390/nu14234946
|
9 |
Anastasia Hyrina, Andrea D. Olmstead, Paul Steven, Mel Krajden, Edward Tam, François Jean. Treatment-Induced Viral Cure of Hepatitis C Virus-Infected Patients Involves a Dynamic Interplay among three Important Molecular Players in Lipid Homeostasis: Circulating microRNA (miR)-24, miR-223, and Proprotein Convertase Subtilisin/Kexin Type 9. EBioMedicine 2017; 23: 68 doi: 10.1016/j.ebiom.2017.08.020
|
10 |
Jung-Hsien Hung, Chung-Hsien Li, Ching-Hua Yeh, Pin-Cheng Huang, Cheng-Chieh Fang, Yen-Fu Chen, Kuo-Jui Lee, Chih-Hung Chou, Hsin-Yun Cheng, Hsien-Da Huang, Marcelo Chen, Ting-Fen Tsai, Anya Maan-Yuh Lin, Chia-Hung Yen, Ann-Ping Tsou, Yu-Chang Tyan, Yi-Ming Arthur Chen. MicroRNA-224 down-regulates Glycine N-methyltransferase gene expression in Hepatocellular Carcinoma. Scientific Reports 2018; 8(1) doi: 10.1038/s41598-018-30682-5
|
11 |
Yahav Eilam, Noam Pintel, Hamdan Khattib, Natalie Shagug, Raged Taha, Dorit Avni. Regulation of Cholesterol Metabolism by Phytochemicals Derived from Algae and Edible Mushrooms in Non-Alcoholic Fatty Liver Disease. International Journal of Molecular Sciences 2022; 23(22): 13667 doi: 10.3390/ijms232213667
|
12 |
Weiping Chang, Lei Zhang, Yao Xian, Zhaoxiang Yu. MicroRNA-33a promotes cell proliferation and inhibits apoptosis by targeting PPARα in human hepatocellular carcinoma. Experimental and Therapeutic Medicine 2017; 13(5): 2507 doi: 10.3892/etm.2017.4236
|
13 |
Tímea Szekerczés, Alíz Gógl, Ildikó Illyés, József Mandl, Katalin Borka, András Kiss, Zsuzsa Schaff, Gábor Lendvai, Klára Werling. Autophagy, Mitophagy and MicroRNA Expression in Chronic Hepatitis C and Autoimmune Hepatitis. Pathology & Oncology Research 2020; 26(4): 2143 doi: 10.1007/s12253-020-00799-y
|
14 |
Zhiwen Luo, Beijie Qi, Yaying Sun, Yisheng Chen, Jinrong Lin, Haocheng Qin, Ning Wang, Runjie Shi, Xiliang Shang, Shiyi Chen, Jiwu Chen. Engineering Bioactive M2 Macrophage‐Polarized, Anti‐inflammatory, miRNA‐Based Liposomes for Functional Muscle Repair: From Exosomal Mechanisms to Biomaterials. Small 2022; 18(34) doi: 10.1002/smll.202201957
|
15 |
Tünde Halász, Gábor Horváth, Gabriella Pár, Klára Werling, András Kiss, Zsuzsa Schaff, Gábor Lendvai. miR-122 negatively correlates with liver fibrosis as detected by histology and FibroScan. World Journal of Gastroenterology 2015; 21(25): 7814-7823 doi: 10.3748/wjg.v21.i25.7814
|
16 |
Alina Simerzin, Elina Zorde‐Khvalevsky, Mila Rivkin, Revital Adar, Jessica Zucman‐Rossi, Gabrielle Couchy, Tania Roskams, Olivier Govaere, Moshe Oren, Hilla Giladi, Eithan Galun. The liver‐specific microRNA‐122*, the complementary strand of microRNA‐122, acts as a tumor suppressor by modulating the p53/mouse double minute 2 homolog circuitry. Hepatology 2016; 64(5): 1623 doi: 10.1002/hep.28679
|
17 |
Andrea R. López-Pastor, Jorge Infante-Menéndez, Óscar Escribano, Almudena Gómez-Hernández. miRNA Dysregulation in the Development of Non-Alcoholic Fatty Liver Disease and the Related Disorders Type 2 Diabetes Mellitus and Cardiovascular Disease. Frontiers in Medicine 2020; 7 doi: 10.3389/fmed.2020.527059
|
18 |
Barbora Hanousková, Barbora Neprašová, Lenka Skálová, Lenka Maletínská, Kateřina Zemanová, Martin Ambrož, Petra Matoušková. High-fructose drinks affect microRNAs expression differently in lean and obese mice. The Journal of Nutritional Biochemistry 2019; 68: 42 doi: 10.1016/j.jnutbio.2019.03.001
|
19 |
Zheng Chen, Jing Ye, Usama Ashraf, Yunchuan Li, Siqi Wei, Shengfeng Wan, Ali Zohaib, Yunfeng Song, Huanchun Chen, Shengbo Cao, R. M. Sandri-Goldin. MicroRNA-33a-5p Modulates Japanese Encephalitis Virus Replication by Targeting Eukaryotic Translation Elongation Factor 1A1. Journal of Virology 2016; 90(7): 3722 doi: 10.1128/JVI.03242-15
|
20 |
Chang-Hai Liu, Javier Ampuero, Antonio Gil-Gómez, Rocío Montero-Vallejo, Ángela Rojas, Rocío Muñoz-Hernández, Rocío Gallego-Durán, Manuel Romero-Gómez. miRNAs in patients with non-alcoholic fatty liver disease: A systematic review and meta-analysis. Journal of Hepatology 2018; 69(6): 1335 doi: 10.1016/j.jhep.2018.08.008
|
21 |
Maria R. Emma, Lydia Giannitrapani, Daniela Cabibi, Rossana Porcasi, Gianni Pantuso, Giuseppa Augello, Rosaria V. Giglio, Noemi Lo Re, Adele R. Capitano, Giuseppe Montalto, Maurizio Soresi, Melchiorre Cervello. Hepatic and circulating levels of PCSK9 in morbidly obese patients: Relation with severity of liver steatosis. Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids 2020; 1865(12): 158792 doi: 10.1016/j.bbalip.2020.158792
|
22 |
Jorge-Luis Torres, Ignacio Novo-Veleiro, Laura Manzanedo, Lucía Alvela-Suárez, Ronald Macías, Francisco-Javier Laso, Miguel Marcos. Role of microRNAs in alcohol-induced liver disorders and non-alcoholic fatty liver disease. World Journal of Gastroenterology 2018; 24(36): 4104-4118 doi: 10.3748/wjg.v24.i36.4104
|
23 |
Ayano Takeuchi-Yorimoto, Yu Yamaura, Masayuki Kanki, Tetsuya Ide, Ayumi Nakata, Takahisa Noto, Masahiro Matsumoto. MicroRNA-21 is associated with fibrosis in a rat model of nonalcoholic steatohepatitis and serves as a plasma biomarker for fibrotic liver disease. Toxicology Letters 2016; 258: 159 doi: 10.1016/j.toxlet.2016.06.012
|
24 |
Catherine Jane Messner, Saskia Schmidt, Dilek Özkul, Carine Gaiser, Luigi Terracciano, Stephan Krähenbühl, Laura Suter-Dick. Identification of miR-199a-5p, miR-214-3p and miR-99b-5p as Fibrosis-Specific Extracellular Biomarkers and Promoters of HSC Activation. International Journal of Molecular Sciences 2021; 22(18): 9799 doi: 10.3390/ijms22189799
|
25 |
Joel Vega-Badillo. ALTERACIONES EN LA HOMEOSTASIS DEL COLESTEROL HEPÁTICO Y SUS IMPLICACIONES EN LA ESTEATOHEPATITIS NO ALCOHÓLICA. TIP 2017; 20(1): 50 doi: 10.1016/j.recqb.2016.11.005
|